Skip to main content

Vascular disease is the commonest cause of death in Westernized countries and its incidence is on the increase in developing countries. It follows that considerable research is directed at establishing effective treatment for acute vascular events. Long-term treatment has also received considerable attention (e.g. for symptomatic relief). Furthermore, effective prevention, whether primary or secondary, is backed by the findings of several landmark trials.

Vascular disease is a complex field with primary care physicians and nurse practitioners as well as several specialties involved. The latter include cardiology, vascular and cardio thoracic surgery, general medicine, radiology, clinical pharmacology and neurology (stroke units). Current Vascular Pharmacology will publish reviews to update all those concerned with the treatment of vascular disease. For example, reviews commenting on recently published trials or new drugs will be included. In addition to clinically relevant topics we will consider 'research-based' reviews dealing with future developments and potential drug targets. Therefore, another function of Current Vascular Pharmacology is to bridge the gap between clinical practice and ongoing research.

Debates will also be encouraged in the correspondence section of this journal.

Publisher: Bentham Science Publishers

Volume 10, Number 2, March 2012

Articles

Aliskiren in Patients with Diabetes: A Systematic Review
pp. 140-146(7)
Authors: C. Rizos, Evangelos; P. Agouridis, Aris; S. Elisaf, Moses

Favourites:
ADD

Genetic Risk Factors for Type 2 Diabetes: Insights from the Emerging Genomic Evidence
pp. 147-155(9)
Authors: E. Ntzani, Evangelia; K. Kavvoura, Fotini

Favourites:
ADD

Pros and Cons of Aggressive Blood Pressure Lowering in Patients with Type 2 Diabetes
pp. 156-161(6)
Authors: G. Kalaitzidis, Rigas; L. Bakris, George

Favourites:
ADD

Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: Pathogenesis and Treatment Options
pp. 162-172(11)
Authors: Tziomalos, Konstantinos; G. Athyros, Vassilios; Karagiannis, Asterios

Favourites:
ADD

Editorial [ Reducing Cardiovascular Risk: Is Low-Density Lipoprotein-Cholesterol (LDL-C) Lowering Enough? ]
pp. 173-177(5)
Authors: S. Kostapanos, Michael; Katsiki, Niki; S. Elisaf, Moses; P. Mikhailidis, Dimitri

Favourites:
ADD

Risk Factors for Cardiovascular Events in Japanese Patients Treated with Fluvastatin from the Long-Term Event Monitoring (LEM) Study
pp. 178-186(9)
Authors: Morishita, Ryuichi; Itakura, Hiroshige; Nakaya, Noriaki; Yoshida, Masayuki; Odawara, Masato; Ichihara, Atsuhiro; Mizuno, Kyoichi

Favourites:
ADD

Pharmacotherapy for the Metabolic Syndrome
pp. 187-205(19)
Authors: L.M. Swislocki, Arthur; Siegel, David; Jialal, Ishwarlal

Favourites:
ADD

Recent Developments on Coronary Microvasculopathy after Heart Transplantation:A New Target in the Therapy of Cardiac Allograft Vasculopathy
pp. 206-215(10)
Authors: Tona, Francesco; Perazzolo Marra, Martina; Fedrigo, Marny; Famoso, Giulia; Bellu, Roberto; Thiene, Gaetano; Gerosa, Gino; Angelini, Annalisa; Iliceto, Sabino

Favourites:
ADD

Telomere/Telomerase System: A New Target of Statins Pleiotropic Effect?
pp. 216-224(9)
Authors: Olivieri, Fabiola; Mazzanti, Ilaria; M. Abbatecola, Angela; Recchioni, Rina; Marcheselli, Fiorella; D. Procopio, Antonio; Antonicelli, Roberto

Favourites:
ADD
Favourites:
ADD

Aldosterone, Mineralocorticoid Receptor and the Metabolic Syndrome:Role of the Mineralocorticoid Receptor Antagonists
pp. 238-246(9)
Authors: Ronconi, Vanessa; Turchi, Federica; Appolloni, Gloria; di Tizio, Valentina; Boscaro, Marco; Giacchetti, Gilberta

Favourites:
ADD

Dealing with the Substance Abuse Epidemic and Infective Endocarditis:Clinical, Immunologic and Pathogenetic Aspects
pp. 247-256(10)
Authors: Starakis, Ioannis; Panos, George; Mazokopakis, Elias

Favourites:
ADD

  • Access Key
  • Free ContentFree content
  • Partial Free ContentPartial Free content
  • New ContentNew content
  • Open Access ContentOpen access content
  • Partial Open Access ContentPartial Open access content
  • Subscribed ContentSubscribed content
  • Partial Subscribed ContentPartial Subscribed content
  • Free Trial ContentFree trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more